Cosmo NV (CMOPF)
72.04
-0.96
(-1.32%)
USD |
OTCM |
Aug 21, 16:00
Cosmo 1 Year Total Returns (Daily) : -1.95% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | -1.95% |
| August 20, 2026 | -0.64% |
| August 19, 2026 | -0.64% |
| August 18, 2026 | -1.43% |
| August 17, 2026 | -1.43% |
| August 14, 2026 | 2.18% |
| August 13, 2026 | 2.18% |
| August 12, 2026 | 5.43% |
| August 11, 2026 | 4.53% |
| August 10, 2026 | 2.51% |
| August 07, 2026 | 4.08% |
| August 06, 2026 | 1.86% |
| August 05, 2026 | 0.72% |
| August 04, 2026 | -0.64% |
| August 03, 2026 | -0.64% |
| July 31, 2026 | 0.72% |
| July 30, 2026 | 2.15% |
| July 29, 2026 | -1.44% |
| July 28, 2026 | -0.23% |
| July 27, 2026 | 0.23% |
| July 24, 2026 | 4.53% |
| July 23, 2026 | 9.35% |
| July 22, 2026 | 1.10% |
| July 21, 2026 | -1.53% |
| July 20, 2026 | -1.53% |
| Date | Value |
|---|---|
| July 17, 2026 | 1.06% |
| July 16, 2026 | 5.43% |
| July 15, 2026 | 3.27% |
| July 14, 2026 | -0.06% |
| July 13, 2026 | 4.86% |
| July 10, 2026 | 4.86% |
| July 09, 2026 | 31.96% |
| July 08, 2026 | 30.83% |
| July 07, 2026 | 33.21% |
| July 06, 2026 | 32.71% |
| July 02, 2026 | 30.99% |
| July 01, 2026 | 30.12% |
| June 30, 2026 | 31.62% |
| June 29, 2026 | 31.45% |
| June 26, 2026 | 30.04% |
| June 25, 2026 | 34.37% |
| June 24, 2026 | 29.22% |
| June 23, 2026 | 34.83% |
| June 22, 2026 | 30.35% |
| June 18, 2026 | 31.62% |
| June 17, 2026 | 39.95% |
| June 16, 2026 | 35.49% |
| June 15, 2026 | 42.72% |
| June 12, 2026 | 38.60% |
| June 11, 2026 | 35.51% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Avadel Pharmaceuticals Plc | 46.02% |
| Jazz Pharmaceuticals Plc | 111.0% |
| Perrigo Co. Plc | -33.93% |
| GH Research Plc | 118.1% |
| Alkermes Plc | 66.31% |